Quick Links

Author: Tina Taylor

Patients ages 8 – 17 with newly diagnosed type 1 diabetes have an opportunity to participate in the PROTECT Study, a clinical trial to see if a study drug called teplizumab can safely preserve insulin-producing cells. Previous clinical studies have suggested a benefit of teplizumab in...

The PACIFIC Study is testing whether group exercise in combination with education on aging and health or behavioral health improves pain and physical function in older adults with knee arthritis. Participant Eligibility 65 years or older Have a diagnosis of knee osteoarthritis Have knee pain that limits your activity Are...

The Diabetes Research team at Seattle Children’s is recruiting young adults ages 18-24 without diabetes for a research study to help us learn more heart health in young adults with type 1 and type 2 diabetes. Young adults with diabetes are at increased risk of...

The primary objective is to assess the long-term safety and tolerability of mavacamten in participants with hypertrophic cardiomyopathy (HCM) previously enrolled in 1 of 2 placebo-controlled trials: MAVERICK-HCM (MYK-461-006) for non-obstructive HCM (nHCM) and EXPLORER-HCM (MYK-461-005) for obstructive HCM (oHCM). All participants will receive active...

SITE PARTNERS
uw-footer